Published in Hepatitis Weekly, May 3rd, 2010
"SVR was achieved in 5 of 7 patients (71%). All 4 patients (100%) who were in relapse with the first course achieved...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.